Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07323862 · ClinicalTrials.gov registry record · NA
Assessment of a Method to Improve Cochlear Implant Users' Speech Perception in Noisy Environments While Maintaining Their Ability to Determine Where a Sound Originates From
A NA study, sponsored by University of Illinois at Urbana-Champaign.
- Not yet
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT07323862: Clinical Trial NA study, sponsored by University of Illinois at Urbana-Champaign.
NCT07323862 is a NA study that has not yet begun recruiting, run by University of Illinois at Urbana-Champaign. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07323862, a NA study, has not yet begun recruiting, sponsored by University of Illinois at Urbana-Champaign.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to determine if a new algorithm can improve speech perception for cochlear implant users. The main questions it aims to answer \[is/are\]: * Does the algorithm improve speech perception in noisy environments? * Does the algorithm allow listeners to determine where a sound is coming from? Participants will * Listen to and repeat sentences presented in the presence of noise * Indicate the location that sounds originated from
Primary Outcome
The speech perception in noise test consists of lists of sentences in the presence of multi-talker babble or diffuse noise. The target location will vary across conditions. Participants will need to repeat back as much of the target sentence as they can.
Interventions
- DEVICE Modifying audio input for cochlear implant processor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2026-01-01 |
| Est. Completion | 2026-08-31 |
| Phase | NA |
What is known before NCT07323862 opens enrollment
NCT07323862 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Modifying audio input for cochlear implant processor is the first listed.
NCT07323862 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07323862 about?
NCT07323862 is a clinical study titled "Assessment of a Method to Improve Cochlear Implant Users' Speech Perception in Noisy Environments While Maintaining Their Ability to Determine Where a Sound Originates From". The goal of this clinical trial is to determine if a new algorithm can improve speech perception for cochlear implant users. The main questions it aims to answer \[is/are\]: * Does the algorithm improve speech perception in noisy environments? * Does the algorithm allow listeners to determine where...
What is the current status of trial NCT07323862?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2026-01-01. Estimated completion is 2026-08-31.
What interventions are being tested in trial NCT07323862?
The interventions under investigation include: Modifying audio input for cochlear implant processor (DEVICE).
Who is sponsoring clinical trial NCT07323862?
This trial is sponsored by University of Illinois at Urbana-Champaign, which has 129 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07323862's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI